News · 26 weeks35-82%
2025-12-142026-06-07
Mix2590d
- SEC Filings14(56%)
- Other9(36%)
- Dividends1(4%)
- Earnings1(4%)
Latest news
25 items- PR22nd Century Group (Nasdaq: XXII) Launches Pinnacle VLN® Trial in California, Opening Another Major New State for Reduced-Nicotine CigarettesInitial 60-Store California Entry Extends XXII's Reduced-Nicotine Rollout Into One of the Nation's Largest and Most Influential Tobacco Markets, With a Pathway to Broader Expansion MOCKSVILLE, N.C., May 21, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced the expansion of Pinnacle VLN® into the state of California through an initial approximately 60-store retail trial, establishing the brand's first retail presence in the state and opening another strategically important market for the Company's FDA-authorized reduced-nicotine cigarette platform. The Californi
- PR22nd Century Group (Nasdaq: XXII) Expands High-Margin Pinnacle Platform With Launch of Pinnacle Pure at Major U.S. RetailersNew Product Introduction Broadens XXII's Fast-Scaling Pinnacle Brand Reinforcing Brand Power, Opening New Retail Doors, and Strengthening the Company's Revenue and Margin Expansion Story MOCKSVILLE, N.C., May 18, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced the launch of Pinnacle Pure, a new tobacco and water style combustible cigarette, further expanding the Company's growing family of Pinnacle branded products, expected to be sold through multiple top national retailers in the United States and over 2,000 locations. The expected launch of Pinnacle Pure
- PR22nd Century Group (Nasdaq: XXII) Ignites Major VLN® Retail Expansion in Metro New York and Northern New Jersey Under Pinnacle BrandVLN® Product Launch in Over 150 New High-Visibility Store Locations Positions XXII to Introduce VLN® to New Consumers and Potentially Capture a Large Adult-Smoker Market, Accelerate High-Margin Revenue MOCKSVILLE, N.C., May 15, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced that shipments are expected to commence of its Pinnacle VLN® cigarette brand for sale through one of the nation's largest purveyors of cigarettes in the US, with distribution expanding to almost 150 stores concentrated in the metro New York area and northern New Jersey. This new rollout m
- PR22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific ReviewFDA filing covers renewal applications for VLN® King and VLN® Menthol King, the first combusted cigarettes authorized as Modified Risk Tobacco Products, as 22nd Century advances its regulatory pathway for continued modified risk marketing status MOCKSVILLE, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco harm reduction company focused on reduced nicotine innovation, today highlighted that the U.S. Food and Drug Administration has filed for scientific review two Modified Risk Tobacco Product, or MRTP, renewal applications for the Company's VLN® King and VLN® Menthol King combusted, filtered cigarettes. The FDA filing marks an important step in the r
- SECSEC Form 10-Q filed by 22nd Century Group Inc.10-Q - 22nd Century Group, Inc. (0001347858) (Filer)
- SEC22nd Century Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - 22nd Century Group, Inc. (0001347858) (Filer)
- PR22nd Century Group Reports First Quarter 2026 Financial ResultsContinues VLN® Commercial Expansion with New Stores Selling Proprietary Branded VLN® Products Expanded PMTA Portfolio and Licensing Strategy Designed to Unlock Further Retail Penetration Opportunities MOCKSVILLE, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced results for the first quarter ended March 31, 2026, and provided an update on recent business highlights. The Company's proprietary reduced nicotine technology is designed to serve adult smokers who want to change their smoking habits by significantly reducing nicotine consumption. 2
- PR22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026MOCKSVILLE, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 28 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction,, will host a webcast on Thursday, May 7, 2026, at 8:00 AM ET to discuss its 2026 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results, discuss progress made in the first quarter and update plans for the 2026 year. The live and archived webcast will be accessible on th
- SEC22nd Century Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - 22nd Century Group, Inc. (0001347858) (Filer)
- SECSEC Form 424B5 filed by 22nd Century Group Inc.424B5 - 22nd Century Group, Inc. (0001347858) (Filer)
- PR22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction LeadershipChairman & CEO Larry Firestone Details 2026 Priorities and Shareholder Value Strategy MOCKSVILLE, N.C., April 29, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 28 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today issued the following letter to stockholders from Lawrence Firestone, the Chairman and Chief Executive Officer of 22nd Century Group, Inc.: Dear Fellow Stockholders, As I reflect on the past year, I am proud of the progress our team has made to form the foundation of the future 22nd Century Group and position the company for long-term growth and success. No
- SECSEC Form DEF 14A filed by 22nd Century Group Inc.DEF 14A - 22nd Century Group, Inc. (0001347858) (Filer)
- PR22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State UniversityMOCKSVILLE, N.C., April 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on nicotine reduction and plant biotechnology, today announced corporate updates regarding a new testing services agreement with North Carolina State University aimed at validating tobacco varieties featuring improved leaf quality and increased crop yields with the same low-nicotine content. The initiative builds upon 22nd Century's proprietary reduced nicotine content technology platform, which utilizes advanced plant breeding and biotechnology to reduce nicotine content in tobacco to minimally addictive levels. The Company's reduced nicotine tobacco is the foun
- SECSEC Form EFFECT filed by 22nd Century Group Inc.EFFECT - 22nd Century Group, Inc. (0001347858) (Filer)
- SECSEC Form 424B5 filed by 22nd Century Group Inc.424B5 - 22nd Century Group, Inc. (0001347858) (Filer)
- SECSEC Form 424B5 filed by 22nd Century Group Inc.424B5 - 22nd Century Group, Inc. (0001347858) (Filer)
- PR22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product InitiativeCompany to Pursue Additional PMTA Submissions, Building on Its Status as the Only Holder of an FDA-Authorized Low Nicotine Combustible Cigarette Branded as VLN® Products Expanded PMTA Portfolio and Licensing Strategy Designed to Address Wider Consumer Preference and Unlock Further Retail Penetration Opportunities MOCKSVILLE, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced an update on the advancement of a 100mm VLN® reduced nicotine content cigarette. The Company's proprietary reduced nicotine technology is designed to serve adult smokers who w
- SECSEC Form S-3 filed by 22nd Century Group Inc.S-3 - 22nd Century Group, Inc. (0001347858) (Filer)
- SECSEC Form S-8 filed by 22nd Century Group Inc.S-8 - 22nd Century Group, Inc. (0001347858) (Filer)
- SECSEC Form 8-K filed by 22nd Century Group Inc.8-K - 22nd Century Group, Inc. (0001347858) (Filer)
- SECSEC Form 10-K filed by 22nd Century Group Inc.10-K - 22nd Century Group, Inc. (0001347858) (Filer)
- PR22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial ResultsVLN® Commercial Expansion Drives Continued Shift Toward Higher Margin Proprietary Branded Products Expanding VLN® Store Counts and State Authorizations Increase Availability of Smoking Harm Reduction Products MOCKSVILLE, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced results for the fourth quarter and fiscal year-ended December 31, 2025, and provided an update on recent business highlights. The Company's proprietary low nicotine technology is designed to serve adult smokers who want to change their smoking habits by significantly reduci
- SECSEC Form 424B5 filed by 22nd Century Group Inc.424B5 - 22nd Century Group, Inc. (0001347858) (Filer)
- PR22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026MOCKSVILLE, N.C., March 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, will host a webcast on Thursday, March 26, 2026, at 8:00 AM ET to discuss its 2025 fourth quarter and full year results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results, discuss progress made in the recent months and update plans for the 2026 year. The live and archived webcast will
- SEC22nd Century Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits8-K - 22nd Century Group, Inc. (0001347858) (Filer)
XXII FAQ
6 questionsWhat does 22nd Century Group Inc. do?
22nd Century Group, Inc., a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets. It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies. 22nd Century Group, Inc. has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd...Where does XXII stock trade?
22nd Century Group Inc. (XXII) is listed on AMEX.What sector and industry is XXII in?
22nd Century Group Inc. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What are analysts saying about XXII?
22nd Century Group Inc. has had 4 recent analyst actions on file. The most recent action was from Alliance Global Partners: Buy with a $500.00 price target on 2022-07-21. Recent price targets range from $500.00 to $600.00.What companies are similar to XXII?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), RGC (Regencell Bioscience Holdings Limited), RLX (RLX Technology Inc.). Compare XXII side-by-side with any of them on Quantisnow.How can I track XXII on Quantisnow?
Quantisnow aggregates 22nd Century Group Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow XXII to receive live email and push alerts on every new disclosure.